The biotechnology sector is showing signs of recovery, with the SPDR S&P Biotech ETF ($XBI) rising by 2.38% as of October 28, 2024. Analysts are noting a potential turnaround in the biotech industry, with various signals indicating a positive shift. UBS has identified the top 10 performing biotech stocks for 2024, which include $SMMT, $RNA, $VKTX, $OCUL, $NRIX, and $VERA. Additionally, early trading has seen small-cap stocks benefiting from the biotech sector's upward movement, as $XBI tests its 50-day moving average. The sentiment among traders suggests optimism for a strong performance in November, traditionally considered a favorable month for biotech stocks.